BioMarin Pharmaceutical (BMRN) Insider Trading & Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free bmrn Stock Alerts $89.49 +0.86 (+0.97%) (As of 04/22/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.84%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$18.01 M Get BMRN Insider Trade Alerts Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMRN Insider Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry BioMarin Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00 4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.00 3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.68 3/5/2024Henry J FuchsInsiderSell35,341$85.18$3,010,346.38 3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00 3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00 2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00 1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00 12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00 12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.20 8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.00 8/10/2023Henry J FuchsInsiderSell12,000$90.43$1,085,160.00 8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.00 8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00 5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00 (Data available from 1/1/2013 forward) BMRN Insider Trading Activity - Frequently Asked Questions Who is on BioMarin Pharmaceutical's Insider Roster? The list of insiders at BioMarin Pharmaceutical includes Brian Mueller, Charles Greg Guyer, Dennis Slamon, Erin Burkhart, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Mark J Alles, Richard A Meier, and V Bryan Lawlis. Learn more on insiders at BMRN. What percentage of BioMarin Pharmaceutical stock is owned by insiders? 1.84% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings. Which BioMarin Pharmaceutical insiders have been buying company stock? The following insider purchased BMRN shares in the last 24 months: Mark J Alles ($314,468.75). How much insider buying is happening at BioMarin Pharmaceutical? Insiders have purchased a total of 3,625 BMRN shares in the last 24 months for a total of $314,468.75 bought. Which BioMarin Pharmaceutical insiders have been selling company stock? The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($3,471,434.67), Charles Greg Guyer ($599,154.80), Erin Burkhart ($205,740.00), George Eric Davis ($6,368,081.74), Henry J Fuchs ($4,095,506.38), Jean Jacques Bienaime ($20,988,285.00), Jeffrey Robert Ajer ($7,116,053.52), Richard A Meier ($318,345.02), and V Bryan Lawlis ($825,265.00). How much insider selling is happening at BioMarin Pharmaceutical? Insiders have sold a total of 462,146 BioMarin Pharmaceutical shares in the last 24 months for a total of $43,987,866.13 sold. More Insider Trading Tools from MarketBeat Related Companies: ALNY Insider Buying UTHR Insider Buying IONS Insider Buying MDGL Insider Buying GMAB Insider Buying TEVA Insider Buying VTRS Insider Buying BGNE Insider Buying KRTX Insider Buying SRPT Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:BMRN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.